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Abstract
Loss of the translational repressor FMRP causes Fragile X syndrome. In healthy neurons, FMRP modulates the local
translation of numerous synaptic proteins. Synthesis of these proteins is required for the maintenance and
regulation of long-lasting changes in synaptic strength. In this role as a translational inhibitor, FMRP exerts profound
effects on synaptic plasticity.
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Background
The long-term maintenance of many forms of synaptic
plasticity requires the synthesis of new proteins. While
the role of experience-dependent somatic gene tran-
scription in long-term memory has been well studied
[1], many mRNAs are trafficked to dendrites suggesting
an additional role for local synaptic control of protein
synthesis [2]. Indeed, activity-dependent translation of
pre-existing dendritic mRNA at the synapse is necessary
for the expression of multiple forms of synaptic plasticity
[3-5]. Fragile X mental retardation protein (FMRP) influ-
ences this synaptic plasticity by functioning as a key
regulator of mRNA translation [6-10].
FMRP was first characterized in the context of Fragile X
syndrome. The FMR1 gene is silenced in Fragile X (FX),
and the consequent loss of FMRP leads to the symptoms
of the disorder, often including intellectual disability and
autism. In the Fmr1 KO mouse model [11], loss of FMRP
results in increased levels of protein synthesis [9,12]. The
downstream consequences of this increase are believed to
at the core of FX pathophysiology [13-15]. Rapid progress
has been made characterizing how loss of FMRP influ-
ences synaptic function and plasticity, and this knowledge
has led to several strategies to correct the disorder that
have been validated in animals and are now being tested
in humans [16-19].
Here we briefly review the evidence, mostly from the
Fmr1 KO mouse, suggesting a role for FMRP in synaptic
plasticity. Although the distinction is not always clear-
cut, it is conceptually important to separate disruptions
of synaptic plasticity that are consequences of altered
brain development from those disruptions of synaptic
plasticity that cause altered brain function in the Fmr1
KO. While both are important for understanding disease
pathophysiology, only the latter is relevant to the ques-
tion of how FMRP contributes to synaptic plasticity in
the wild-type brain.
FMRP regulates translation
FMRP is an RNA-binding protein and a repressor of
translation which is well-conserved from mouse to hu-
man. FMRP associates with mRNAs through one of three
RNA-binding domains [20,21], in some cases in conjunc-
tion with adaptor proteins [22,23]. There is evidence that
FMRP can repress translation both by blocking initiation
and elongation [15,24,25]. A point mutation in one
FMRP/mRNA binding domain is sufficient to recapitulate
plasticity phenotypes seen in the Fmr1 KO mouse [26]
and in at least one case FX in a human patient [27]. Thus
it is likely that FMRP regulates plasticity mainly in its role
as a repressor of translation.
FMRP is regulated by posttranslational modifications.
Phosphorylated FMRP stalls ribosomal translocation and
inhibits translation, whereas dephosphorylation of FMRP
upregulates translation [28-30]. Bidirectional regulation
of FMRP phosphorylation by the S6 kinase and protein
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phosphatase 2A (PP2A) in response to activity provide a
potential link between synaptic stimulation and local
translation [24].
FMRP is well-positioned to regulate synaptic plasticity
FMRP is well-positioned to be a key regulator of synap-
tic plasticity for three main reasons. First, the protein is
found in dendritic spines [31-34], important postsynaptic
sites of plasticity induction and maintenance. Secondly,
FMRP regulates dendritic mRNA translation [16,17], which
is required for multiple forms of plasticity [35]. Finally,
FMRP itself is dynamically regulated by activity: experience
and synaptic activation can trigger its local translation
and rapid degradation, in addition to the posttranslational
regulation mentioned above. Multiple experimental manip-
ulations associated with synaptic plasticity have been
shown to increase FMRP levels, including exposure to an
enriched environment, a complex learning task, and phar-
macological activation of group 1 metabotropic glutatmate
receptors (mGluRs) [31,36-38]. Importantly, FMRP is syn-
thesized rapidly, on the same time scale (10–30 minutes)
as induction of stable synaptic plasticity [37]. In hippocam-
pal cultures, activity- and mGluR-dependent increases
in dendritic FMRP may result from increased trafficking
of existing FMRP, rather than de novo FMRP synthesis
[33,39,40]. Either way, FMRP is an ideal candidate to be in-
volved in regulating synaptic plasticity because of its rapid,
transient rise in dendrites following well-characterized
plasticity induction paradigms, as well as its role as an in-
hibitor of translation.
FMRP regulates mGluR-LTD via protein synthesis
Long-term potentiation (LTP) and long-term depression
(LTD) are well-characterized forms of synaptic plasticity
associated with learning and memory. These persistent
changes in synaptic strength can be induced by a variety
of manipulations and their expression mechanisms are
diverse. Different induction protocols rely on different
mechanisms for maintenance, including the requirement
for protein synthesis. A particularly compelling example
of a form of plasticity requiring local translation is me-
tabotropic glutamate receptor-dependent LTD (mGluR-
LTD) in the CA1 region of the hippocampus. Activation
of group 1 mGluRs (mGluR1 and 5), either with paired-
pulse low-frequency synaptic stimulation (PP-LFS) [4] or
with the selective agonist (S)-3,5-dihydroxyphenylglycine
(DHPG) [41-43], results in a persistent decrease in synap-
tic strength that is mechanistically distinct from classical
NMDA receptor (NMDAR)-dependent LTD [41,44]. It is
important to note that there are several mechanisms
downstream of mGluR activation that can depress synap-
tic transmission, and these can be differentially expressed
depending on the induction protocol, age, rearing history,
and species (e.g., [44-48]). However, under appropriate
experimental conditions the maintenance of mGluR-LTD
requires rapid protein synthesis within minutes of induc-
tion [4,49]. This protein synthesis is likely to be synaptic,
as mGluR-LTD can still be induced if the dendritic layer is
physically severed from the cell body layer [4]. mGluR-
LTD is expressed, in part, by the removal of AMPA recep-
tors from synapses, which also requires rapid de novo
translation [50]. The new protein synthesis may be in-
structive rather than merely permissive for synaptic plasti-
city since activation of group 1 mGluRs rapidly stimulates
protein synthesis in hippocampal slices [12], dendrites and
synaptoneurosomes [51,52].
Fmr1 knockout mice show enhanced hippocampal
mGluR-LTD [8,14,49,53] (Table 1). A subsequent study
found a similar enhancement in cerebellar mGluR-LTD,
which shares many of the same expression mechanisms
[54]. Consistent with the electophysiological data, loss
of FMRP leads to excessive mGluR-mediated AMPAR
internalization [55]. In addition, mGluR-LTD no longer
requires new protein synthesis in the Fmr1 KO mice
[49,56]. These results, combined with what is known
about FMRP function, suggest that FMRP acts to inhibit
the synthesis of proteins required for mGluR-LTD. In
the absence of FMRP, these “LTD proteins” are already
available or over-expressed in dendrites resulting in en-
hanced magnitude and protein synthesis-independent
persistence of this form of plasticity (Figure 1A) [13].
Conversely, postnatal overexpression of FMRP reduces
the magnitude of mGluR-LTD in both wildtype and
Fmr1 KO neurons [49] and restores its protein synthesis
dependence [57]. Moreover, reducing mGluR5 signaling
in Fmr1 KO mice restores both protein synthesis rates
and LTD magnitude in the hippocampus to wildtype
levels [53,58], suggesting that mGluR5 and FMRP act
in functional opposition to maintain an optimal level of
synaptic protein synthesis throughout development and
into adulthood (Figure 1A).
L-LTP appears normal in Fmr1 KO mice
While the effects of protein synthesis inhibition on
mGluR-LTD can be seen within minutes, most forms of
synaptic plasticity do not require de novo synthesis until
several hours after induction. This is best characterized
by late phase LTP (L-LTP), a persistent form of potenti-
ation lasting at least 4 hours. The late maintenance
phase of L-LTP requires protein synthesis but initial in-
duction does not [59,60]. Due to FMRP’s conjectured
role in translation regulation, L-LTP was one of the first
forms of plasticity studied in the Fmr1 KO mouse [61].
Interestingly, no difference has been found in the magni-
tude of L-LTP in the Fmr1 KO [61,62]. The fact that re-
moval of FMRP affects protein synthesis-dependent LTD
but not LTP suggests that FMRP may specifically regulate
the translation of proteins required for the expression of
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LTD (Figure 1B). However, while the magnitude of L-LTP
is unchanged, it is possible that L-LTP is qualitatively dif-
ferent in its requirement for new protein synthesis when
FMRP is absent, as is the case for mGluR-LTD (and LTP
priming, see below). Therefore, it will be important to test
the protein synthesis-dependency of L-LTP in Fmr1 KO
mice to show that FMRP truly does not play a role in
regulating the persistence of LTP.
Alternatively, FMRP may be required for the regula-
tion of local but not somatic translation in the context
of L-LTP (Figure 1C). L-LTP is traditionally induced by
multiple trains of high frequency tetanus or theta burst
stimulation, protocols that rely on cell-wide transcrip-
tion and translation [63-65]. L-LTP was characterized in
the Fmr1 KO mouse using these classical paradigms
[61,62]. However, using a less intense induction protocol
Table 1 Fragile X mouse synaptic plasticity phenotypes
Category Region Fragile X Mouse Phenotype Age References
mGluR LTD hippocampus enhanced P25-30 Huber et al., 2002; Hou et al., 2006;
Bhattacharya et al., 2012;
Michalon et al., 2012
mGluR LTD hippocampus does not require
new protein synthesis
4-12 wk Nosyreva and Huber, 2006; Hou,
et al., 2006; Zang et al., 2009**
mGluR LTD hippocampus *enhanced and not PS-dependent P35-42 Iliff et al., 2012
mGluR LTD cerebellum enhanced 3-7 wk Koekkoek et al., 2005
mGluR LTD hippocampus enhanced and does not
require new protein synthesis
3-7 wk Volk et al., J Neurosci, 2007
LTP hippocampus NONE 20-26 wk; 8-10 wk;
3-12 month
Godfraind et al., 1996; Li et al.,
2002; Larson et al., 2005
L-LTP hippocampus NONE 5-7 wk; 2-4 month Paradee et al., 1999;
Zhang et al., J 2009
LTP hippocampus deficient 2 wk; 6-8 wk Hu et al., 2008; Shang et al., 2009
LTP hippocampus deficient with weak stimulus;
normal with strong stimulus
2-3 month Lauterborn et al., 2007
LTP hippocampus enhanced B-adrenergic-facilitated
heterosynaptic LTP (PS-dependent)
3-4 month Connor et al., 2011
LTP priming hippocampus does not require new protein
synthesis (mGluR-dependent)
6-10 wk Auerbach and Bear, 2010
LTP anterior cingulate ctx deficient 6-8 wk Zhao et al., 2005; Xu et al., 2012
LTP anterior cingulate ctx impaired facilitation of LTP
by 5-HT2AR agonist
6-8 wk Xu et al., 2012
LTP somatosensory, temporal ctx deficient 8-10 wk; 3 month Li et al., 2002; Hayashi et al., 2007
LTP somatosensory ctx delayed window for plasticity P3-10 Harlow et al., 2010
LTP visual ctx deficient (mGluR-dependent) P13-25 Wilson and Cox, 2007
LTP anterior piriform ctx deficient in aged mice;
normal in 3-6 mo mice
6-18 month Larson et al., 2005
LTP amygdala impaired (mGluR-dependent) 6-8 wk; 3.5-6 mo Zhao et al., 2005;
Suvrathan et al., 2010
STD-LTP somatosensory ctx deficient with weak stimulus P10-18 Desai et al., 2006
STD-LTP prefrontal ctx deficient with weak stimulus;
normal with strong stimulus
P14-23 Meredith et al., 2007
homeostasis hippocampus deficient translation-
dependent scaling
P6-7 slice culture Soden and Chen, 2010
homeostasis hippocampus normal transcription-
dependent scaling
P6-7 slice culture Soden and Chen, 2010
experience-dependent visual ctx (in vivo) altered ocular dominance plasticity LTD Dolen et al., 2007
experience-dependent somatosensory ctx deficient experience-dependent
plasticity (induced by whisker trimming)
LTD Bureau et al., 2008
LEGEND: Fragile X mouse models have multiple altered forms of synaptic plasticity across multiple brain regions. The majority of phenotypes were assessed in the
Fmr1 KO mouse which lacks FMRP. *Assessed using a CGG knock-in mouse which models FX premutation. **Assessed using an FMRP point mutant mouse with
disrupted FMRP-mRNA binding.
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results in L-LTP that is maintained specifically by local
dendritic translation [5,66]. This form of L-LTP, similar
to mGluR-LTD, is sensitive to inhibitors of translation
but not transcription, and can be maintained in isolated
dendrites. It will be interesting to determine if this lo-
cally expressed form of L-LTP is regulated by FMRP.
FMRP regulates LTP priming
While the role of FMRP in L-LTP is unclear, FMRP is
known to be involved in LTP in other contexts. In par-
ticular, FMRP is involved in regulation of an mGluR-
dependent form of metaplasticity that sets the threshold
for LTP. Originally described in rats [67], weak activation
of group 1 mGluRs, in itself insufficient for LTD induc-
tion, facilitates the subsequent induction of LTP (“LTP
priming”). As with mGluR-LTD, this facilitation requires
translation but not transcription [68]. This prompted the
examination of the role of FMRP in LTP priming [69].
mGluR-dependent priming of LTP is of comparable mag-
nitude in WT and Fmr1 KO mice; however, while LTP
priming requires acute stimulation of protein synthesis in
WT mice, it is no longer protein synthesis-dependent in
the Fmr1 KO. Thus, while mGluR-LTD and LTP priming







































Figure 1 The role of FMRP in translation-dependent synaptic plasticity. (A) FMRP and mGluR5 impose opposite regulation on the local
mRNA translation required for mGluR-LTD expression. In the absence of FMRP, there is excessive protein synthesis and exaggerated LTD. (B)
While FMRP is known to regulate the translation required for LTD, evidence suggests it is not involved in the expression of L-LTP. There may be
different pools of mRNA available at the synapse that are differentially required for LTD versus LTP, and FMRP may specifically regulate the pool
required for LTD. (C) FMRP is explicitly involved in the regulation of dendritically localized translation and may not regulate somatic translation.
Consequently, FMRP may only impact forms of plasticity that require local translation, such as mGluR-LTD. (D) In addition to mGluR-LTD, FMRP
regulates the protein synthesis involved in mGluR-dependent facilitation of LTP. This finding suggests that the proteins whose translation is
controlled by FMRP may be involved in bi-directional maintenance of plasticity rather than being specific to LTD.
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mGluR-stimulated protein synthesis in the hippocampus,
both processes are altered by the removal of FMRP
(Figure 1D). These results suggest that the mRNA under
translational control of FMRP may code for proteins re-
quired for bidirectional changes in synaptic strength.
Thus, the proteins regulated by FMRP should be concep-
tualized as plasticity gatekeepers rather than solely “LTD
proteins.”
The induction threshold for LTP and STD-LTP is raised in
Fmr1 KO mice
In Fmr1 KO hippocampal slices, LTP induction is defi-
cient with a weak 5 theta burst protocol but is normal
with a strong 10 theta burst protocol (Figure 2A) [70].
In addition, FMRP modulates the induction threshold for
spike-timing dependent long-term potentiation (STD-
LTP). This form of Hebbian plasticity is induced by tem-
porally staggered presynaptic and postsynaptic activity
within a very short window [71,72]. In somatosensory
and prefrontal cortices, STD-LTP is deficient in Fmr1 KO
neurons [73,74]. However, if the postsynaptic stimulus
strength is increased from a single spike to a burst of five
spikes, STD-LTP does occur in KO neurons (Figure 2A)
[74]. Therefore FMRP is not required for expression of
STD-LTP, but the threshold is raised in its absence. A
possible mechanism for ongoing regulation of LTP thresh-
olds by FMRP is discussed later in this review.
FMRP and other translation-dependent forms of plasticity
In addition to its role in translation-dependent forms of
Hebbian plasticity, FMRP can also modulate some forms
of homeostatic plasticity. Synaptic scaling is a form of
homeostatic plasticity that acts to keep the strength of
synapses within a functional range in response to extreme
changes in activity. Broadly, a decrease in activity leads to a
subsequent cell-wide increase in synaptic strength (“scaling
up”) and an increase in activity leads to a decrement in
synaptic strength (“scaling down”) [75]. Two types of scal-
ing up have been described in hippocampal slice culture:
one that requires transcription [76] and one that requires
local translation [77]. Interestingly, only the translation-
dependent form of synaptic scaling is deficient in neurons
lacking FMRP. Postsynaptic viral expression of FMRP cor-
rects deficient translation-dependent scaling up in Fmr1
KO neurons [78]. Scaling down of synapses in response
to high levels of activity (following prolonged blockade
of inhibition) has also been observed [79] and requires
mGluR5 activation [80,81]. However, the role of FMRP and
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Figure 2 FMRP and Kv4.2 regulate the threshold for inducing synaptic potentiation. (A) FMRP sets the threshold for LTP and STD-LTP. Fmr1
KO mice have deficient hippocampal LTP and cortical STD-LTP only with a “weak” induction protocol. (B) Kv4.2 is a dendritic A-type K+ channel
that attenuates action potential backpropagation (bAP) and dendritic excitability. (C) Inhibition of Kv4.2 restores LTP following a weak induction
protocol in Fmr1 KO mice.
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While the role of FMRP has been best characterized in
mGluR-dependent forms of plasticity, it is not specific
to these receptors. Removal of FMRP occludes TrkB-
mediated increases in protein synthesis [12] and alters
other forms of G protein-coupled receptor (GPCR)-
dependent LTD and LTP [82,83]. The common thread
between these processes is their reliance on local den-
dritic translation. Indeed, evidence suggests that FMRP
may specifically be important for the regulation of local
rather than somatic translation (Figure 1C), as removal of
FMRP affects translation but not transcription-dependent
forms of Hebbian and homeostatic plasticity.
FMRP and translation-independent plasticity
While many forms of translation-dependent synaptic
plasticity are abnormal in Fmr1 KO mice, other forms of
hippocampal plasticity, including NMDAR-dependent
LTD and early-phase LTP, are normal [8,61,69,84,85].
These observations suggest that FMRP regulates plasticity
mainly in its role as a regulator of translation. However, re-
moval of FMRP has also been shown to affect some forms
of synaptic plasticity that do not require de novo transla-
tion, such as early-phase LTP in other brain areas, includ-
ing the cortex and amygdala [61,85-89]. Some of these
effects could be explained by FMRP modulation of protein
synthesis-dependent plasticity thresholds; however it seems
likely that many represent end-stage consequences of al-
tered synaptic development in the Fmr1 KO.
A case in point is altered LTP in the amygdala. A substan-
tial deficit in basal transmission was reported at the same
synapses that showed impaired LTP [88]. Reduced synaptic
connectivity might have caused the defective LTP, and
might have arisen as a consequence of increased FMRP-
dependent protein synthesis during the development of
amygdala circuitry.
Candidate plasticity gating proteins regulated by FMRP
In order to determine how FMRP regulates synaptic
plasticity, we must identify the synaptic proteins whose
translation is regulated by FMRP. FMRP has a wide var-
iety of targets - it has been shown to selectively bind ap-
proximately 4% of the mRNA in the mammalian brain
[90]. Recently, over 800 mRNA binding targets of FMRP
were identified using a novel high throughput cross-
linking immunoprecipitation (HITS-CLIP) assay [10].
These targets include genes coding for pre- and post-
synaptically expressed proteins: 27% of pre-synaptic pro-
tein mRNAs (90 genes) and 23% of postsynaptic protein
mRNAs (257 genes) are FMRP targets [10]. More specific-
ally, the HITS-CLIP study found that 31% of mRNAs cod-
ing for proteins in the NMDAR complex (58 genes), 62%
in the mGluR5 complex (32 genes), and 33% in the
AMPAR complex (3 genes) are FMRP targets. These three
receptor complexes are important for the induction and
maintenance of synaptic plasticity, suggesting that FMRP
likely acts broadly as a translational regulator rather than
solely regulating one or two “plasticity proteins.”
The finding that many FMRP targets encode presynap-
tic proteins is interesting and illuminating. In the mature
nervous system the evidence for local protein synthesis
in axons or axon terminals is still sparse; however during
early axon development and synapse formation local
protein synthesis is believed to play an important role in
pathway and target selection [91,92]. Thus, the absence
of FMRP regulation of protein synthesis during early de-
velopment very likely alters synaptic connectivity well
before the onset of experience-dependent postnatal plas-
ticity. In addition, outside the CNS, local control of
translation in sensory afferent terminals plays a role in
nociceptive sensitization and neuropathic pain [93].
FMRP is localized to these terminals and Fmr1 KO mice
show altered nociceptive sensitization [94]. These results
suggest that in the spinal cord, presynaptic FMRP may
inhibit local translation and can regulate pain plasticity
even into adulthood.
We have discussed two major categories of plasticity
defects in Fmr1 KO mice: (1) forms of plasticity requir-
ing FMRP/local translation for their maintenance
(mGluR-LTD) and (2) forms of plasticity where FMRP
regulates their induction threshold (STD-LTP). We will
discuss a few proteins in both categories that are likely in-
volved given their regulation by FMRP and their known
roles in plasticity maintenance and threshold-setting in
wild-type synapses. These “candidate proteins” are meant
to serve as exemplars of how FMRP might regulate synap-
tic plasticity.
Plasticity maintenance proteins: MAP1B, Arc, and STEP
Recent work has identified proteins whose translation
is regulated by FMRP and are involved in mGluR-LTD,
including microtubule-associated protein 1B (MAP1B)
and activity-regulated cytoskeleton-associated protein (Arc)
[17,18]. MAP1B is required for mGluR-depdendent AMPA
receptor endocytosis [95], the mechanism by which
mGluR-LTD is expressed. FMRP associates with MAP1B
mRNA and represses its translation [90,96-98], and Fmr1
KO mice show increased hippocampal MAP1B expression
[49]. However, there may be mouse strain and region-
specific variations in how FMRP regulates MAP1B transla-
tion. For example, in the cerebellum and hippocampus of
FVB mice, FMRP may positively regulate MAP1B expres-
sion [99].
Arc is involved in AMPAR endocytosis [100] and is
upregulated in dendrites following mGluR activation
[101,102] and behavior [103]. Arc is required for hippo-
campal mGluR-LTD and L-LTP, which are both protein
synthesis-dependent, and Arc−/− mice have multiple
learning deficits [101,102,104]. FMRP binds Arc mRNA
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and suppresses its translation. As a result, Arc expres-
sion is increased in Fmr1 KO dendrites [98,105,106].
Since (a) mGluR-LTD is increased in Fmr1 KO mice, (b)
Arc is increased in Fmr1 KO dendrites, and (c) Arc is re-
quired for mGluR-LTD, it seems likely that FMRP regu-
lates mGluR-LTD via Arc. This hypothesis was tested
directly using Fmr1/Arc double knockout mice which
show deficient (rather than exaggerated) mGluR-LTD
[8,102]. This finding suggests that increased Arc expres-
sion may partially account for the enhanced mGluR-
LTD seen in Fmr1 KO mice.
Mechanistically, dephosphorylation of FMRP by the
phosphatase PP2A is required for rapid mGluR-mediated
increases in Arc protein. However in Fmr1 KO neurons,
Arc levels are basally increased, occluding a further effect
of DHPG treatment. Acute viral reintroduction of FMRP
into Fmr1 KO neurons normalizes dendritic Arc levels
and restores rapid mGluR-mediated Arc synthesis. This
provides further evidence that the acute loss of FMRP, ra-
ther than developmental abnormality, underlies synaptic
plasticity phenotypes in the Fmr1 knockout mouse. ere-
gulation of translation.
In addition to MAP1B and Arc, numerous other can-
didate LTD proteins have been identified in the Fmr1 KO
mouse. One interesting example is striatal-enriched pro-
tein tyrosine phosphatase (STEP). Translation of STEP is
increased during mGluR-LTD [107,108], and STEP mRNA
binds to FMRP [10]. Genetic reduction of STEP corrects
behavioral phenotypes in the Fmr1 KO mouse; but it is
not known whether corresponding LTD phenotypes are af-
fected [109]. Additional candidate proteins include APP
[110,111], OPHN1 [112], CaMKIIα [49,98,113], PSD-95
[113-115], and PI3K [116].
Plasticity threshold-regulating proteins: Kv4.2
A recent review discussing the role of potassium chan-
nels in Fragile X provides insight into how FMRP may
regulate excitability [117]. FMRP directly regulates the
translation of at least three potassium channels: Kv4.2,
Kv3.1b, and Slack [118-122]. FMRP’s control of Kv4.2
translation may have indirect consequences on regulat-
ing the threshold for LTP and STD-LTP induction.
Kv4.2 is an A-type potassium channel that regulates
dendritic excitability and the extent of action potential
backpropagation [123,124]. A-type currents act to dampen
dendritic excitability and AP backpropagation (Figure 2B).
By modulating the strength of backpropagation, Kv4.2 also
has been shown to regulate the threshold for LTP and
STD-LTP [123,125]. In the absence of Kv4.2, dendrites are
more excitable and there is a decreased threshold for LTP
induction [123,126].
Fmr1 KO mice have an increased threshold for LTP
and STD-LTP induction, as discussed earlier (Figure 2A)
[73,74]. One potential hypothesis for this phenomenon
is that FMRP inhibits the translation of Kv4.2, and Fmr1
KO mice have excessive Kv4.2 protein synthesized in
dendrites. Indeed, FMRP does directly associate with
and negatively regulate the translation of Kv4.2 mRNA
[118]. But does this account for the altered LTP/STD-
LTP threshold in Fmr1 KO mice? Pharmacological in-
hibition of Kv4.2 in Fmr1 KO mice does correct deficient
weak-stimulus hippocampal LTP while strong-stimulus
LTP remains unchanged [118] (Figure 2C). This finding
suggests that the increased threshold for LTP in the
Fmr1 KO mouse may be accounted for by increased
translation of the potassium channel Kv4.2.
Interestingly, another group has recently shown that
under their conditions, FMRP positively regulates the
translation of Kv4.2 [119]. This study did not address the
potential consequences of decreased Kv4.2 in the Fmr1
KO on synaptic plasticity. One would expect increased
dendritic excitability, which has been previously reported
in other contexts [127], and a decreased LTP threshold.
It will be important to determine the precise experimen-
tal and in vivo conditions under which each of these op-
posing patterns of regulation can occur, but it is clear
that FMRP’s regulation of Kv4.2 in either direction
would have important consequences for plasticity.
FMRP, synaptic plasticity and learning
Long-lasting synaptic potentiation and depression have
long been considered potential neural correlates of learn-
ing and memory. In conjunction with FMRP’s role in syn-
aptic plasticity in multiple brain areas, FMRP is also
important for a wide range of behavioral learning tasks in
mice. Fmr1 KO mice show deficient amygdalar trace fear
memory [87], cerebellar learning [54], inhibitory avoid-
ance learning [58], and have difficulties with a prefrontal
cognitive learning task [128]. Drosophila mutants lacking
FMRP also have impaired long-term memory [129]. Over-
all, learning and memory deficits in the Fmr1 KO mouse
are a likely behavioral consequence of abnormal synaptic
plasticity.
Conclusions
FMRP participates in the regulation of numerous forms
of synaptic plasticity, including mGluR-LTD, LTP prim-
ing, and synaptic scaling. It seems that FMRP is particu-
larly important for synaptic plasticity that requires
dendritic translation, as these forms of plasticity all re-
quire local translation and FMRP is a well-established
regulator of local translation. The current evidence sug-
gests that FMRP plays an essential role in regulating the
synaptic expression of proteins required for bidirectional
changes in synaptic strength (Figure 1). It is likely that
FMRP controls the expression of proteins not only acutely
required for expression of synaptic plasticity, but also pro-
teins that regulate the threshold for plasticity induction
Sidorov et al. Molecular Brain 2013, 6:15 Page 7 of 11
http://www.molecularbrain.com/content/6/1/15
(Figure 2). Therefore FMRP’s role in synaptic plasticity is
two-fold: it regulates the translation of proteins that dir-
ectly participate in the induction and expression of plasti-
city as well as proteins that can indirectly modulate the
properties of plasticity.
A key goal in the Fragile X field is to identify which
proteins are regulated by FMRP and how increases or
decreases in these proteins may account for phenotypes
of the disorder. Determining the proteins that are regu-
lated by FMRP (and altered in FX) will also lead to a bet-
ter understanding of the neuronal processes that are
essential for synaptic plasticity and learning/memory.
The HITS-CLIP screen has identified hundreds of candi-
dates and a significant number of these are putatively in-
volved in synaptic plasticity. It is unlikely that there is
one global “plasticity protein” - multiple proteins likely
regulate different processes in parallel. Mapping which
proteins are essential for which processes is the impor-
tant next step for understanding the role of FMRP in the
pathological and non-pathological brain.
The Fmr1 KO mouse provides a model for assessing
the role of FMRP in synaptic plasticity - but on their
own, studies in Fmr1 KO mice leave open the possibility
that developmental rather than acute changes result in
altered synaptic plasticity. In multiple contexts, acute
manipulations of FMRP suggest that FMRP does actively
regulate synaptic plasticity as a regulator of translation.
There is ample evidence that FMRP can directly impact
synaptic plasticity through its control of protein synthe-
sis. Future work that allows for better temporal and
spatial control of FMRP expression will help dissect the
role of FMRP in development from its acute effects on
synaptic plasticity.
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